https://www.selleckchem.com/products/vbit-4.html
8%, with similar incidence in patients treated with and without NIV. Among NIV users (26.4%), NIV failure occurred in 39.3%. Higher MPI scores at admission significantly predicted in-hospital mortality (β=4.46, p0.0001) among patients with ARF and NIV failure (β=7.82, p=0.001) among NIV users. MPI showed good discriminatory power for NIV failure (area under the curve 0.72, 95% CI 0.58-0.85, p0.001) with optimal cut-off at MPI value of 0.84. MPI at admission might be a useful tool to early detect patients more at risk of in-hospit
Gefällt mir
Kommentar
Teilen
